Evidence map›Paper›PMID 31971587›Full record

ArticleGenome biology and evolution2020

Genomic Analysis of Mycobacterium tuberculosis Isolates and Construction of a Beijing Lineage Reference Genome.

Woei-Fuh Wang, Mei-Yeh Jade Lu, Ting-Jen Rachel Cheng, Yi-Ching Tang, Yu-Chuan Teng, Teh-Yang Hwa, Yi-Hua Chen, Meng-Yun Li, Mei-Hua Wu, Pei-Chun Chuang and 3 more

Abstract read
In one paragraph

Article in Genome biology and evolution, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. High-Accuracy Long-Read Sequencing ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
  3. Pan-lineage Mycobacterium tuberculosis reference genome for enhanced molecular diagnosis.DNA research : an international journal for rapid publication of reports on genes and genomes · 2024
    Article
  4. Large-scale Pan Genomic Analysis ofEvolutionary bioinformatics online · 2024
    Article
  5. Article
  6. First-line drug resistance profiling ofAMIA ... Annual Symposium proceedings. AMIA Symposium · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Woei-Fuh WangBiodiversity Research Center, Academia Sinica, Taipei, Taiwan.
Mei-Yeh Jade LuBiodiversity Research Center, Academia Sinica, Taipei, Taiwan.
Ting-Jen Rachel ChengGenome Research Center, Academia Sinica, Taipei, Taiwan.
Yi-Ching TangBiodiversity Research Center, Academia Sinica, Taipei, Taiwan.
Yu-Chuan TengBiodiversity Research Center, Academia Sinica, Taipei, Taiwan.
Teh-Yang HwaBiodiversity Research Center, Academia Sinica, Taipei, Taiwan.
Yi-Hua ChenBiodiversity Research Center, Academia Sinica, Taipei, Taiwan.
Meng-Yun LiBiodiversity Research Center, Academia Sinica, Taipei, Taiwan.
Mei-Hua WuTuberculosis Research Center, Centers for Disease Control, Taipei, Taiwan.
Pei-Chun ChuangTuberculosis Research Center, Centers for Disease Control, Taipei, Taiwan.
Ruwen JouTuberculosis Research Center, Centers for Disease Control, Taipei, Taiwan.
Chi-Huey WongGenome Research Center, Academia Sinica, Taipei, Taiwan.
Wen-Hsiung LiBiodiversity Research Center, Academia Sinica, Taipei, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis, kills over 1 million people worldwide annually. Development of drug resistance (DR) in the pathogen is a major challenge for TB control. We conducted whole-genome analysis of seven Taiwan M. tuberculosis isolates: One drug susceptible (DS) and five DR Beijing lineage isolates and one DR Euro-American lineage isolate. Developing a new method for DR mutation identification and applying it to the next-generation sequencing (NGS) data from the 6 Beijing lineage isolates, we identified 13 known and 6 candidate DR mutations and provided experimental support for 4 of them. We assembled the genomes of one DS and two DR Beijing lineage isolates and the Euro-American lineage isolate using NGS data. Moreover, using both PacBio and NGS sequencing data, we obtained a high-quality assembly of an extensive DR Beijing lineage isolate. Comparative analysis of these five newly assembled genomes and two published complete genomes revealed a large number of genetic changes, including gene gains and losses, indels and translocations, suggesting rapid evolution of M. tuberculosis. We found the MazEF toxin-antitoxin system in all the seven isolates studied and several interesting mutations in MazEF proteins. Finally, we used the four assembled Beijing lineage genomes to construct a high-quality Beijing lineage reference genome that is DS and contains all the genes in the four genomes. It contains 212 genes not found in the standard reference H37Rv, which is Euro-American. It is therefore a better reference than H37Rv for the Beijing lineage, the predominant lineage in Asia.

Indexed as

Bacterial ProteinsBeijingDrug Resistance, Multiple, BacterialGenome, BacterialINDEL MutationMutationMycobacterium tuberculosisPhylogenyBacterial ProteinsBeijing lineage referencedrug resistanceMycobacterium tuberculosisTB genomes

Identifiers

PMID31971587
PMCPMC7058165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.